Beyond The Printed Page
-
The Path That Brought Lara Sullivan To Biopharma
12/20/2021
Lara Sullivan, M.D., to be featured in an upcoming issue of Life Science Leader, discusses the entrepreneurial path the brought her to the CEO role at Pyxis Oncology.
-
How Trust Based Is Your Joint Venture?
12/13/2021
In the January 2022 feature article, Lara Sullivan, M.D., CEO of Pyxis Oncology, talks about building her company, doing so in “stealth mode,” and executing a joint venture. Here’s a video snippet of the conversation as a sneak peek for the upcoming article.
-
From Compliance To Outsourcing — Advice From 4 Biopharma Manufacturing Execs
12/9/2021
From improving quality and compliance to key outsourcing decisions, five biopharmaceutical execs offer advice on top-of-mind manufacturing topics.
-
From Politics To Industry Reputation – Top Of Mind Topics For Execs In Biopharma
12/8/2021
From trade relations to industry reputations, five biopharmaceutical executives share their thoughts on top-of-mind topics as we ready for 2022 and beyond.
-
What Trends Are Biopharma Finance Execs Following?
12/7/2021
Seven finance execs note what trends they are paying closest attention to in 2022 and beyond.
-
What Trends And Innovations Are Biopharma Manufacturing Execs Watching?
12/6/2021
Five biopharmaceutical manufacturing execs share the trends and innovations they are paying closest attention to and why.
-
Does It Matter Where You Locate Your Biopharma Anymore?
12/3/2021
Four biopharmaceutical execs weigh if geographic proximity (e.g., being in a major biopharma hub) is as important today as it once was.
-
How Will Biopharma Look In 2032?
12/2/2021
Three biopharmaceutical executives share perspectives on how the industry might look in the next decade.
-
What Trends Are 9 Biopharma CEOs Paying Attention To?
12/1/2021
Nine biopharmaceutical CEOs share thoughts on the key trends they are paying attention to and why.
-
A Tough Business Lesson To Learn
10/25/2021
Lisa Conte, founder and CEO of Jaguar Health, shares her wisdom from corporate collaboration lessons learned the hard way.